DIALIZE-Outcomes — SZC null for arrhythmia-related CV events in HD; early stop (2025) — Trial Summary

DIALIZE-Outcomes — SZC null for arrhythmia-related CV events in HD; early stop (2025): Randomized, placebo-controlled trial of sodium zirconium cyclosilicate (SZC) versus placebo in adults on thrice-weekly maintenance hemodialysis with predialysis hyperkalemia (serum K ≥5.5 mmol/L). SZC started at 5

References

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.